Written by MATTHEW PERRONE

Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems in pregnant women.

The Food and Drug Administration posted its analysis of the pill ahead of a public meeting next week where academic and other experts will weigh in on its safety and effectiveness. The agency isn’t required to follow the group’s advice.

The FDA scientists said their review identified several potential risks, including possible toxicity and birth defects. Regulators also noted Merck collected far less safety data overall on its drug than was gathered for other COVID-19 therapies.

All COVID-19 drugs currently authorized by the FDA require an injection or IV, which limits their use. If authorized, Merck’s drug would be the first that patients could take at home to ease symptoms and speed recovery. It is already authorized for emergency use in the U.K.

With cases rising again across most of the U.S., regulators are expected to greenlight Merck’s drug as an important new weapon to help ease the strain on hospitals. But the FDA review is key to determining who will be eligible and how widely it might be prescribed.

FDA will ask its independent advisers whether the drug’s benefits outweigh its risks and if its use should be restricted for pregnant women.

 

Related Stories
‹
Pfizer, US Ink $5.29B Deal for Possible COVID-19 Treatment
Written by TOM MURPHY The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regulators authorize it, the nation’s largest purchase agreement yet for a coronavirus therapy. Pfizer asked the Food and Drug Administration on Tuesday to authorize emergency use of the experimental pill, which […]
COVID-19 Pill Rollout Stymied by Shortages as Omicron Rages
Written by MATTHEW PERRONE Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections. The problem is that production is not yet at full strength and that the pill […]
Pfizer Agrees To Let Other Companies Make Its COVID-19 Pill
Written by MARIA CHENG Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. In a statement issued Tuesday, Pfizer said it would grant a license for the […]
Pfizer Says COVID-19 Pill Cut Hospital, Death Risk by 90%
Written by MATTHEW PERRONE Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market. Currently all COVID-19 treatments used in the U.S. require […]
UK Authorizes Merck Antiviral Pill, 1st Shown To Treat COVID
Written by MATTHEW PERRONE and MARIA CHENG Britain granted conditional authorization on Thursday to the first pill shown to successfully treat COVID-19 so far. It also is the first country to OK the treatment from drugmaker Merck, although it wasn’t immediately clear how quickly the pill would be available. The pill was licensed for adults […]
Merck Asks US FDA To Authorize Promising Anti-COVID Pill
Written by MATTHEW PERRONE Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon to the world’s arsenal against the pandemic. If cleared by the Food and Drug Administration — a decision that could come in a matter of weeks — it would […]
Merck Says Experimental Pill Cuts Worst Effects of COVID-19
Written by MATTHEW PERRONE Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use. If cleared, the drug would be the first pill shown […]
What Does Full Approval of Pfizer’s COVID-19 Vaccine Mean?
Written by MATTHEW PERRONE What does full approval of Pfizer’s COVID-19 vaccine mean? It means Pfizer’s shot for people 16 and older has now undergone the same rigorous testing and regulatory review as dozens of other long-established vaccines. COVID-19 vaccines in the U.S. were initially rolled out under the Food and Drug Administration’s emergency use […]
US Regulators Give Full Approval to Pfizer COVID-19 Vaccine
Written by LAURAN NEERGAARD and MATTHEW PERRONE The U.S. gave full approval to Pfizer’s COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus mutant yet. The vaccine made by Pfizer and its partner BioNTech now carries the strongest endorsement from the […]
U.S. Parents Excited Over Prospect of Virus Shots for Children
Written by HEATHER HOLLINGSWORTH and TODD RICHMOND After more than a year of fretting over her 13-year son with a rare liver disease, Heather Ousley broke into tears when she learned that he and millions of other youngsters could soon be eligible for the COVID-19 vaccine. “This day is the best day in the history of […]
›